000250 — Sam Chun Dang Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapHigh Flyer

Market Cap
KR₩26tn
Enterprise Value
KR₩26tn
Revenue
KR₩232bn

Annual balance sheet for Sam Chun Dang Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	97,025	86,248	92,744	134,917	129,058
Net Total Accounts Receivable
Net Total Receivables	38,589	39,004	35,111	61,387	55,641
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	168,920	157,749	163,906	242,532	241,759
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	74,112	87,212	90,009	103,595	143,094
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	345,997	372,793	408,022	519,772	561,231
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	54,081	38,160	57,957	93,421	106,572
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	171,902	199,052	187,523	253,667	285,212
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	174,095	173,741	220,499	266,105	276,020
Total Liabilities & Shareholders' Equity	345,997	372,793	408,022	519,772	561,231
Total Common Shares Outstanding